
Image via citybiz — regional US deals
Last updated
Bicara Therapeutics: Leadership Change
Bicara Therapeutics (Nasdaq: BCAX) appointed biotechnology executives Jeremy Bender and Christy Oliger to Board of Directors as clinical-stage oncology company transitions toward commercialization of lead candidate ficerafusp alfa. Founding board member Kiran Mazumdar-Shaw retired from board.
Source: citybiz — regional US deals
The leadership read
Commercial operations and go-to-market build-out: Chief Commercial Officer or VP Commercial roles; sales force and market access teams (Bender's background at Day One Biopharmaceuticals pre-Servier acquisition demonstrates commercialization expertise); regulatory and compliance leadership (preparing for regulatory approval and launch); market access and reimbursement specialists (Oliger's $13B+ U.S. oncology portfolio experience at Genentech). Manufacturing scale-up and supply chain roles to support commercial launch.
Market context: Against a Talent Market Index of 102.6 (Warm) (down 1.8 month-on-month), Americas is at easing (-2.2pts) on signal share.
Bicara Therapeutics: 3 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 3 tracked across 38 days.
Also at Bicara Therapeutics →
More signals across Americas
Leadership Change · Americas
Owens Corning →Owens Corning elevated Todd Fister to President and COO and appointed experienced CFO Jonathan Collins, signaling finance leadership reshuffle alongside flat sales and sharp net income decline in Q2 2026.
Leadership Change · Americas
Newmark →Long-serving CEO Barry Gosin is stepping down after 48 years but transitioning to chairman of the operating committee to guide future growth.
Leadership Change · Americas
Celsius →Rockstar Energy founder Russ Savage is leading an insurgency against Celsius leadership following a disappointing Q2 earnings miss. Significant shareholder pressure for management ouster.
Leadership Change · Americas
SiriusXM →Jenny Tartikoff appointed Senior VP & Head of Communications at SiriusXM, effective Aug 10, 2026. She reports to President and Chief Content Officer Scott Greenstein and will oversee content and advise leadership.
Leadership Change · Americas
The Trade Desk →The Trade Desk replaced four senior executives (CFO, CMO, CCO, CBDO) within two months (June-July 2026). First guidance under new leadership projects 12% revenue decline YoY for Q3 2026.
Leadership Change · Americas
Lemonade →Lemonade (LMND) announced a planned chief financial officer transition, disclosed alongside Q2 2026 quarterly earnings update. Leadership change occurred during volatile market conditions for the company (30-day share price decline of 33.16%).
Intelligence powered by Autonodal ↗
